| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41590-019-0371-8 |
| P698 | PubMed publication ID | 30936492 |
| P50 | author | Sebastian Amigorena | Q37728726 |
| Marianne Burbage | Q86423930 | ||
| P2093 | author name string | Marine Gros | |
| P2860 | cites work | Mutant MHC class II epitopes drive therapeutic immune responses to cancer | Q36817092 |
| Cross-presentation by dendritic cells | Q38025870 | ||
| m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways | Q38632272 | ||
| The transcription factor TFEB acts as a molecular switch that regulates exogenous antigen-presentation pathways | Q40883748 | ||
| Rethinking m6A Readers, Writers, and Erasers. | Q48009024 | ||
| Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity | Q48198762 | ||
| mA facilitates hippocampus-dependent learning and memory through YTHDF1 | Q58570655 | ||
| WDFY4 is required for cross-presentation in response to viral and tumor antigens | Q58571296 | ||
| Regulation of Antigen Export to the Cytosol During Cross-Presentation | Q61807977 | ||
| m6A modification controls the innate immune response to infection by targeting type I interferons | Q67200928 | ||
| Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells | Q75719938 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 518-520 | |
| P577 | publication date | 2019-05-01 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Translate less, prime better, to improve anti-tumor responses | |
| P478 | volume | 20 |
| Q91875003 | The RNA modification N6-methyladenosine as a novel regulator of the immune system | cites work | P2860 |
Search more.